Suppr超能文献

相似文献

4
Fingolimod treatment abrogates chikungunya virus-induced arthralgia.
Sci Transl Med. 2017 Feb 1;9(375). doi: 10.1126/scitranslmed.aal1333.
5
Chikungunya virus infections: time to act, time to treat.
Curr Opin Virol. 2017 Jun;24:25-30. doi: 10.1016/j.coviro.2017.03.016. Epub 2017 Apr 14.
6
Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Antiviral Res. 2016 Mar;127:50-6. doi: 10.1016/j.antiviral.2016.01.006. Epub 2016 Jan 18.
7
Evaluation of medicinal herbs for Anti-CHIKV activity.
Virology. 2019 Jul;533:45-49. doi: 10.1016/j.virol.2019.04.007. Epub 2019 Apr 29.
8
Chikungunya virus: host pathogen interaction.
Rev Med Virol. 2011 Mar;21(2):78-88. doi: 10.1002/rmv.681. Epub 2011 Mar 15.
9
Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.
Sci Rep. 2018 Jan 30;8(1):1860. doi: 10.1038/s41598-018-20305-4.
10
Molecular Mimicry between Chikungunya Virus and Host Components: A Possible Mechanism for the Arthritic Manifestations.
PLoS Negl Trop Dis. 2017 Jan 26;11(1):e0005238. doi: 10.1371/journal.pntd.0005238. eCollection 2017 Jan.

引用本文的文献

2
Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection.
PLoS Pathog. 2024 Dec 30;20(12):e1012816. doi: 10.1371/journal.ppat.1012816. eCollection 2024 Dec.
3
Evaluation of Withania somnifera based supplement for immunomodulatory and antiviral properties against viral infection.
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):100955. doi: 10.1016/j.jaim.2024.100955. Epub 2024 Oct 9.
9
Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients.
J Ayurveda Integr Med. 2022 Jul-Sep;13(3):100589. doi: 10.1016/j.jaim.2022.100589. Epub 2022 May 23.
10
Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.
Adv Protein Chem Struct Biol. 2022;129:275-379. doi: 10.1016/bs.apcsb.2021.11.007. Epub 2022 Jan 29.

本文引用的文献

2
Suramin treatment reduces chikungunya pathogenesis in mice.
Antiviral Res. 2016 Oct;134:89-96. doi: 10.1016/j.antiviral.2016.07.025. Epub 2016 Aug 27.
3
The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
J Virol. 2016 Oct 14;90(21):9743-9757. doi: 10.1128/JVI.01382-16. Print 2016 Nov 1.
4
Blood-brain barrier permeability of bioactive withanamides present in Withania somnifera fruit extract.
Phytother Res. 2014 Aug;28(8):1260-4. doi: 10.1002/ptr.5118. Epub 2014 Jan 23.
5
Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis.
Biomed Res Int. 2013;2013:973516. doi: 10.1155/2013/973516. Epub 2013 Aug 28.
6
Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study.
PLoS Negl Trop Dis. 2013;7(3):e2137. doi: 10.1371/journal.pntd.0002137. Epub 2013 Mar 21.
8
Arthritogenic alphaviruses--an overview.
Nat Rev Rheumatol. 2012 May 8;8(7):420-9. doi: 10.1038/nrrheum.2012.64.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验